Rise and shine, everyone. Another busy day is getting under way here on the Pharmalot corporate campus, where we are hustling various short people off to this or that school house. To cope, we are preparing, of course, the mandatory cup of stimulation. No doubt, your own schedule is chocked full of challenges, too. To help you along, here are some interesting tidbits. Hope your day goes well...
Crucell Posts Loss On South Korea Writedown (Reuters)
Pfizer Defeats Generic Challenge To Effexor In Australia (Bloomberg News)
Italy's Hospital Drug Launch Threatens Reimbursement (PharmaTimes)
Teva To Raise Stake In Mediwound To 51 Percent (Reuters)
Johnson & Johnson Breached Japan's Fair Trade Rules (Bloomberg News)
UK Withdraws Legal Aid From Epilim Case (The Guardian)
Antibiotic Research Subsidies Weighed By US (New York Times)
Allergan And Its Plans To Market Botox For Migraines (Orange County Business Journal)